8353 |
Ab00279-1.6 |
Anti-EGFR [C225 (Cetuximab)] |
100 μg |
支 |
6360.00 |
8354 |
Ab00279-1.4-BT |
Anti-EGFR [C225 (Cetuximab)] |
1 mg |
支 |
19920.00 |
8355 |
Ab00279-1.4 |
Anti-EGFR [C225 (Cetuximab)] |
200 μg |
支 |
4680.00 |
8356 |
Ab00279-1.1-BT |
Anti-EGFR [C225 (Cetuximab)] |
1 mg |
支 |
19920.00 |
8357 |
Ab00279-1.1 |
Anti-EGFR [C225 (Cetuximab)] |
200 μg |
支 |
4680.00 |
8358 |
Ab00278-6.4-VPT |
Anti-Nerve Growth Factor [alphaD11] |
10 mg |
支 |
16680.00 |
8359 |
Ab00278-6.4-VPS |
Anti-Nerve Growth Factor [alphaD11] |
25 mg |
支 |
39180.00 |
8360 |
Ab00278-6.4-VPB |
Anti-Nerve Growth Factor [alphaD11] |
100 mg |
支 |
68460.00 |
8361 |
Ab00278-6.4 |
Anti-Nerve Growth Factor [alphaD11] |
200 μg |
支 |
4680.00 |
8362 |
Ab00278-6.1-VPT |
Anti-Nerve Growth Factor [alphaD11] |
10 mg |
支 |
16680.00 |
8363 |
Ab00278-6.1-VPS |
Anti-Nerve Growth Factor [alphaD11] |
25 mg |
支 |
39180.00 |
8364 |
Ab00278-6.1-VPB |
Anti-Nerve Growth Factor [alphaD11] |
100 mg |
支 |
68460.00 |
8365 |
Ab00278-6.1 |
Anti-Nerve Growth Factor [alphaD11] |
200 μg |
支 |
4680.00 |
8366 |
Ab00278-1.4-VPT |
Anti-Nerve Growth Factor [alphaD11] |
10 mg |
支 |
16680.00 |
8367 |
Ab00278-1.4-VPS |
Anti-Nerve Growth Factor [alphaD11] |
25 mg |
支 |
39180.00 |
8368 |
Ab00278-1.4-VPB |
Anti-Nerve Growth Factor [alphaD11] |
100 mg |
支 |
68460.00 |